Parul Tandon DO PhD FRCPC
@ptandonGI
Followers
1K
Following
5K
Media
51
Statuses
922
"IBDologist", Clinician Scientist @UHN, Assistant Prof @UofT, @UofTGastroHep alum, @SinaiHealth IBD alumni, PhD Clin Epi @ihpmeuoft; lucky husband and father!
Toronto, Ontario, Canada
Joined November 2018
#SundayRead☕️🐓 from #CC360 Editor 🚧to #IBD care in Hispanics vs WhiteNH ⬆️ ⏳Delay>1yr in dx 💲Financial difficulty 💊Beliefs meds are toxic ⬇️🤝Community support 🚨Need culturally sensitive care, meds support tools, community resources #EquityInIBD
https://t.co/t8IPDbx2ID
0
6
21
Congratulations to Neeraj Narula on being recognized with the 2025 Distinguished Service Award from the Canadian IBD Research Consortium! @McMasterU @machealthsci @getgutsycanada!!!
0
2
16
Our recent SRMA looks at impact of #IBD therapies on bowel urgency, with all therapies improving BU significantly compared to placebo (some as soon as 48hrs after start of therapy) https://t.co/g83XeE4Q5h
@vipuljairath @NarulaNeeraj @DrLexGI Chris Ma (@CalgaryIBD)
onlinelibrary.wiley.com
This systematic review and meta-analysis found that several advanced therapies for inflammatory bowel disease, including IL-23 and JAK inhibitors, are effective in alleviating bowel urgency, an...
0
3
8
What a ride! Devastating feeling but so proud of this amazing team! Thank you for all the memories!
It was a magical ride with all of you. Our city, our home, our fans showed up on the grand stage...and we couldn't be prouder.
0
0
4
Excited to have @EdwardLoftus2 @MayoClinic give keynote address at #OAG25 updating @ontario_gastros on #acuteUC with thanks to @ptandonGI @UofTGastroHep moderating #yyz
0
4
8
📢 New article on this #JCAGJeudi 📰 Infections in primary sclerosing cholangitis and inflammatory bowel disease: a systematic review and meta-analysis ✍️by Navneet Natt, Tyrel Jones May, Gurpreet Malhi, Jennifer Dumond, Aliya Gulamhusein, Parul Tandon
0
3
7
☕️🐓#SundayRead 🧒🏻👦🏻born to mom w #IBD have ⬆️ healthcare utilization by age 5 ⬆️Endoscopy & abdo imaging ⬆️Mental health visits, neurodevelopmental concerns Causes? ?⬇️Threshold to ✔️sympt by parents & 🩺 ?⬆️VEO-IBD ?Effect of in-utero exposure to🔥 https://t.co/DOMbA2qG3O
1
9
23
Health Care Utilization of Children Born to Women With and Without Inflammatory Bowel Disease in the First 5 Years of Life: A Population-Cohort Study Tandon, et al. 📕 https://t.co/hLeIbe2nO2
@ptandonGI @vwaimeih @MLongMD @JasmohanBajaj
0
8
19
Don’t miss our Keynote Address: Acute Severe Colitis with Dr. Edward V. Loftus, Jr. Learn about clinical management, salvage therapies & the role of early surgery in IBD care. learn more! https://t.co/inAYZXWijQ
#gastroenterology #Networking #OAG25 #OAG25
0
1
2
👉Join me this upcoming Monday to discuss how to use imaging to guide IBD care! #MondayNightIBD @iUSCAN @BowelUltrasound @DrMikeDolinger @KrugCleveland @amelia_kellar @DrPhil_Gu @IBD_FloMD @BettenworthDb @novakkerri @RuneWilkens @MariangelaAllo3 @DrSagami @guthealthmd
📌Sept 29 for a convo led by @CathyLuMD 📡Guidelines make it sound simple, but IRL how do CLN+ IUS +FCP guide your #IBD care? 🗳️PreConvo #IBDPolls 🆓#CME👉🏽 https://t.co/sd42H9vTGV Supported by educational grants @abbvie @JNJInnovation @TakedaPharma Where are you in your 🩺?
1
9
19
Check out our brief report in the @AmJGastro ! We report on 8 patients who developed an eczematous eruption following discontinuation of their JAK inhibitor, with 2 patients having biopsy-proven atopic dermatitis @IBDMD @UChicagoIBD
https://t.co/wqz9hgGutr
journals.lww.com
ients with IBD who developed de novo AD after withdrawal of JAKi therapy. RESULTS: Median time to AD onset was 7 days (interquartile range 2–12). Two cases with biopsy-confirmed AD resolved after...
4
6
20
Don’t miss the Ontario Association of Gastroenterology’s 29th Annual Conference & Business Meeting this October 24–26 at the Marriott Downtown Toronto Eaton Centre! Connect, learn, and lead in gastroenterology. https://t.co/i6HtHjsyDg
#gastroenterology #Networking #OAG25 #OAG25
0
1
2
UHN's bold Canada Leads initiative aims to attract top US researchers amid funding cuts, creating a unique opportunity to recruit global talent. With a vision to elevate excellence, Toronto is set to be a leading hub for scientific innovation. Read more: https://t.co/d7v0CgjrS0
1
17
45
📣 Do you live with #IBD and speak Arabic, Farsi, Tagalog, Hindi, Mandarin, Punjabi or Spanish? SAIA is collaborating with @laura_tee_mdgi’s team at Sinai Health to run virtual focus groups to create culturally tailored IBD education materials in multiple languages 🌍 This will
2
4
10
Please be sure to register as spots are limited!
Spotlight on Faculty 🚨 Just Announced! Meet the full international & Canadian faculty for Great Lakes IBD Forum 2025 – a powerhouse lineup of global IBD experts. 📅 Don’t miss this premier event in IBD care. 🔗 https://t.co/1hi7TYud2x
#IBD #GL2025 #Gastroenterology
0
3
5
Our new meta-analysis in the Journal of IBD demonstrated that IBD was associated with EoE, independent of IBD subtype. Thanks to @ptandonGI for the mentorship and support throughout and the team for this great collaboration! @DrLexGI @ChhibbaTarun
https://t.co/2lDXwjcqFM
academic.oup.com
AbstractBackground. The association between inflammatory bowel disease (IBD) and eosinophilic esophagitis (EoE) remains unclear. We aimed to perform a syst
3
13
43
✅ Vedolizumab: Summary of Key Clinical Trials 🔹 GEMINI 1 & 2 IV vedolizumab is effective for: – UC: Strong induction & maintenance – CD: Modest induction, robust maintenance 🔹 EARNEST 📊 First RCT showing efficacy in chronic pouchitis, supporting post-IPAA use. 🔹 REPREVIO 🔁
5
21
87
We are proud to introduce @jalpa_devi as SAIA’s new Research Liaison 👏🏽 Learn more about Jalpa & SAIA’s Research Committee: https://t.co/Q0ehjEOH6L We are thrilled to have Jalpa onboard to support our research initiatives, advance knowledge, and serve our #IBD community 🙏🏽
8
11
44